Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics. 2022

Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
Unidad Universitaria de Investigación, División de Investigación, Facultad de Medicina, UNAM-Hospital Infantil de México Federico Gómez, Universidad 3000, CP 04510, Mexico City, Mexico.

Acute lymphocytic leukemia is the most common type of cancer in pediatric individuals. Glucose regulated protein (GRP78) is an endoplasmic reticulum chaperone that facilitates the folding and assembly of proteins and regulates the unfolded protein response pathway. GRP78 has a role in survival of cancer and metastasis and cell-surface associated GRP78 (sGRP78) is expressed on cancer cells but not in normal cells. Here, we explored the presence of sGRP78 in pediatric B-ALL at diagnosis and investigated the correlation with bona fide markers of leukemia. By using a combination of flow cytometry and high multidimensional analysis, we found a distinctive cluster containing high levels of sGRP78, CD10, CD19, and CXCR4 in bone marrow samples obtained from High-risk leukemia patients, which was absent in the compartment of Standard-risk leukemia. We confirmed that sGRP78+CXCR4+ blood-derived cells were more frequent in High-risk leukemia patients. Finally, we analyzed the dissemination capacity of sGRP78 leukemia cells in a model of xenotransplantation. sGRP78+ cells emigrated to the bone marrow and lymph nodes, maintaining the expression of CXCR4. Testing the presence of sGRP78 and CXCR4 together with conventional markers may help to achieve a better categorization of High and Standard-risk pediatric leukemia at diagnosis.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000091342 Endoplasmic Reticulum Chaperone BiP An ENDOPLASMIC RETICULUM specific chaperone of the HSP70 family. They are involved in folding and oligomerization of secreted and membrane proteins and ENDOPLASMIC RETICULUM STRESS related UNFOLDED PROTEIN RESPONSE. Binding-immunoglobulin Protein Molecular Chaperone,Glucose Regulated Protein 78 kDa,Grp78,HSPA5 Protein,Heat-Shock Protein 5,Molecular Chaperone BiP,Molecular Chaperone GRP78,BiP, Molecular Chaperone,Binding immunoglobulin Protein Molecular Chaperone,GRP78, Molecular Chaperone,Heat Shock Protein 5,Protein, HSPA5

Related Publications

Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
January 2020, Cancer biomarkers : section A of Disease markers,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
January 2009, Clinical lymphoma & myeloma,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
November 2011, Haematologica,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
September 1997, Cancer causes & control : CCC,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
December 1996, Cancer,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
July 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
February 2024, Cancers,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
December 2012, Frontiers of medicine,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
July 2001, Leukemia & lymphoma,
Tania Angeles-Floriano, and Guadalupe Rivera-Torruco, and Paulina García-Maldonado, and Esmeralda Juárez, and Yolanda Gonzalez, and Israel Parra-Ortega, and Armando Vilchis-Ordoñez, and Briceida Lopez-Martinez, and Lourdes Arriaga-Pizano, and Dario Orozco-Ruíz, and José Refugio Torres-Nava, and Paula Licona-Limón, and Francisco López-Sosa, and Alhelí Bremer, and Lourdes Alvarez-Arellano, and Ricardo Valle-Rios
January 2011, European journal of dermatology : EJD,
Copied contents to your clipboard!